Sectors
PCRX
Pacira BioSciences, Inc.
24.62
1 x 24.45
2 x 24.64
bid
ask
+
0.19
0.78%
09:41 AM
timesize
| Ytd | -4.87% | |
| 1y | -2.22% |
24.45
day range
24.62
18.80
52 week range
27.66
| Open | 24.49 | Prev Close | 24.43 | Low | 24.45 | High | 24.62 | Mkt Cap | 965.48M |
| Vol | 7.24K | Avg Vol | 538.03K | EPS | 2.60 | P/E | 9.44 | Forward P/E | 8.73 |
| Beta | 0.27 | Short Ratio | 14.82 | Inst. Own | 115.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 24.68 | 200-d Avg | 23.57 | 1yr Est | 29.67 |
| Income Statement | |||
| Total Revenue | 192.40M | ||
| Revenues (USD) | 192.40M | ||
| Cost of Revenue | 44.16M | ||
| Gross Profit | 148.24M | ||
| Operating Expenses | 143.97M | ||
| Research and Development Expense | 30.24M | ||
| Selling, General and Administrative Expense | 91.81M | ||
| Operating Income | 4.27M | ||
| Interest Expense | 3.62M | ||
| Income Tax Expense | -2.10M | ||
| Net Income | 4.65M | ||
| Net Income Common Stock | 4.65M | ||
| Net Income Common Stock (USD) | 4.65M | ||
| Consolidated Income | 4.65M | ||
| Earnings per Basic Share | 0.12 | ||
| Earnings per Basic Share (USD) | 0.12 | ||
| Earnings per Diluted Share | 0.12 | ||
| Earning Before Interest & Taxes (EBIT) | 6.18M | ||
| Earning Before Interest & Taxes (USD) | 6.18M | ||
| Weighted Average Shares | 39.46M | ||
| Weighted Average Shares Diluted | 40.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 205.88M | ||
| Cash and Equivalents (USD) | 205.88M | ||
| Investments | 69.00M | ||
| Investments Current | 45.16M | ||
| Investments Non-Current | 23.84M | ||
| Trade and Non-Trade Receivables | 132.42M | ||
| Current Assets | 615.22M | ||
| Property, Plant & Equipment Net | 175.20M | ||
| Total Assets | 1.24B | ||
| Debt Current | 10.30M | ||
| Total Debt | 412.12M | ||
| Current Liabilities | 122.01M | ||
| Debt Non-Current | 401.82M | ||
| Total Liabilities | 572.00M | ||
| Accumulated Retained Earnings (Deficit) | -191.75M | ||
| Accumulated Other Comprehensive Income | 3.24M | ||
| Shareholders Equity | 671.98M | ||
| Shareholders Equity (USD) | 671.98M | ||
| Assets Non-Current | 628.76M | ||
| Total Debt (USD) | 412.12M | ||
| Goodwill and Intangible Assets | 305.13M | ||
| Inventory | 134.57M | ||
| Liabilities Non-Current | 449.99M | ||
| Trade and Non-Trade Payables | 17.51M | ||
| Tax Assets | 124.60M | ||
| Tax Liabilities | 4.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 21.96M | ||
| Net Cash Flow from Financing | -7.65M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 61.57M | ||
| Capital Expenditure | -1.34M | ||
| Issuance (Purchase) of Equity Shares | 2.18M | ||
| Issuance (Repayment) of Debt Securities | -5.00M | ||
| Net Cash Flow from Investing | 11.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 13.10M | ||
| Net Cash Flow from Operations | 57.46M | ||
| Share Based Compensation | 14.96M | ||